SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy
Advanced Science · 2024-09 · 11 (36)
DOI: 10.1002/advs.202403019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.07.2024. Verfasst von Shimeng Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Immunotherapy, Tumor-Associated Macrophages, Tumor Microenvironment, Phenotype. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
The main challenge for immune checkpoint blockade (ICB) therapy lies in immunosuppressive tumor microenvironment (TME). Repolarizing M2‐like tumor‐associated macrophages (TAMs) into inflammatory M1 phenotype is a promising strategy for cancer immunotherapy. Here, this study shows that the tumor suppressive protein SHISA3 regulates the antitumor functions of TAMs. Local delivery of mRNA encoding Shisa3 enables cancer immunotherapy by reprogramming TAMs toward an antitumoral phenotype, thus enhancing the efficacy of programmed cell death 1 (PD‐1) antibody. Enforced expression of Shisa3 in TAMs increases their phagocytosis and antigen presentation abilities and promotes CD8 + T cell‐mediated antitumor immunity. The expression of SHISA3 is induced by damage/pathogen‐associated molecular patterns (DAMPs/PAMPs) in macrophages via nuclear factor‐κB (NF‐κB) transcription factors. Reciprocally, SHISA3 forms a complex with heat shock protein family A member 8 (HSPA8) to activate NF‐κB signaling thus maintaining M1 polarization of macrophages. Knockout Shisa3 largely abolishes the antitumor efficacy of combination immunotherapy with Toll‐like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPLA) and PD‐1 antibody. It further found that higher expression of SHISA3 in antitumoral TAMs is associated with better overall survival in lung cancer patients. Taken together, the findings describe the role of SHISA3 in reprogramming TAMs that ameliorate cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
- Key Laboratory of Molecular Biophysics, the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, 430074, P. R. China.
- Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, 518063, P. R. China.
ORCID-Profile: Shuai Chen
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
Zitieren
APA
Zhang, S., Yu, B., Sheng, C., Yao, C., Liu, Y., Wang, J., Zeng, Q., Mao, Y., Bei, J., Zhu, B., & Chen, S. (2024). SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy. Advanced Science, 11(36). https://doi.org/10.1002/advs.202403019
Vancouver
Zhang S, Yu B, Sheng C, Yao C, Liu Y, Wang J, et al. SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy. Advanced Science. 2024;11(36). doi:10.1002/advs.202403019
BibTeX
@article{Zhang2024,
author = {Zhang, Shimeng and Yu, Bingbing and Sheng, Chunjie and Yao, Chen and Liu, Yang and Wang, Jing and Zeng, Qi and Mao, Yizhi and Bei, Jinxin and Zhu, Bin and Chen, Shuai},
title = {SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {36},
doi = {10.1002/advs.202403019}
}
EUVIMED